K. Cheng et al.
O
D
D
1) 0 oC, 30 min
D
D
O
D
D
HO
OH
D
O
P OH
OH
P
2) 138 oC, 18 h
38%
+
H2N
OH
H2N
D
HO
1
2
O
O
O
D
D
O
O
P OH
OH
D
THF/NaHCO3/H2O
79%
N
N
O
H
D
2
+
O
3
4
Scheme 1.
mass spectra (CIMS) were obtained using a Finnigan 4600 mass (2 ꢁ 20 mL), dried (Na2SO4) and concentrated in vacuo to afford
spectrometer unless otherwise noted. 2H nuclear magnetic 4 as a waxy light yellow solid (184 mg, 79%). 1HNMR (Jeol
resonance (2H NMR, 500 MHz) was recorded on a Bruker Avance Eclipse, 300 MHz, CDCl3) d 5.26–5.36 (m, 8H), 2.76–2.80 (m, 6H),
500 instrument in deuterium depleted water (2–3 ppm deuter- 2.25 (brt, 2H), 2.0–2.06 (m, 4H), 1.66–1.68 (m, 2H), 1.24–1.33 (m,
ium, Cambridge Isotope Laboratories, Inc.) with the values given 6H), 0.87 (t, J = 6.7 Hz, 3H); MS (Agilent 1100 Series HPLC-MS, CI)
in ppm (D2O as internal standard at 4.80 ppm). 31P nuclear m/z 430 (Mꢀ1) and 432 (M11). Anal. calcd. for
magnetic resonance (31P NMR) spectra were recorded on a C22H34D4NO5Pꢂ0.7CHCl3: C, 52.93; H and D as H, 7.58; N, 2.72.
Varian Gemini-300 instrument in D2O with the values given in Found: C, 52.90; H and D as H, 7.71; N, 2.65. The presence of
ppm (H2O as internal standard at 4.80 ppm). The melting point chloroform was confirmed by the NMR of 4 in DMSO.
was determined on a Bu¨chi B-545 melting point apparatus and
is uncorrected. Combustion analyses were determined at Acknowledgement
Atlantic Microlabs, Atlanta, GA.
We would like to thank Dr Klaus Gawrisch and Dr Walter Teague
of the Laboratory of Membrane Biochemistry and Biophysics
2-Aminoethyl dihydrogen phosphate-1,1,2,2-d4 (2)
(LMBB) in NIAAA for 2H NMR spectral data. The authors also
To an ice-cold solution of 2-aminoethanol-1,1,2,2-d4 (1, 1.0 g,
express their appreciation to Noel Whittaker and Wesley White
15.4 mmol) in water (20 mL), was added dropwise, over 10 min, a
of the Laboratory of Analytical Chemistry for mass spectral data
solution of phosphoric acid (3.0 g, 30.8 mmol) in water (20 mL).
and 31P NMR spectral data. The work of the Drug Design and
After the mixture was stirred at 01C for 30 min, most of the water
Synthesis Section, CBRB, NIDA, & NIAAA, was supported by the
was removed in vacuo. A desiccant flask holding phosphorus
NIH Intramural Research Programs of the National Institute on
pentoxide was attached, and the flask assembly was evacuated
Drug Abuse (NIDA) and the National Institute of Alcohol Abuse
to a pressure of 3–5 mm. The reaction flask was heated to 1381C
and Alcoholism, and the work of the Neuroendocrinology
(oil bath) and kept at this temperature for 18 h. After cooling to
Section, Laboratory of Physiologic Studies, was supported by the
room temperature, the residue was dissolved in water (7 mL)
NIH Intramural Research Programs of the National Institute of
and ethanol (3 mL) was added. The white crystalline solid that
Alcohol Abuse and Alcoholism. The authors (B.S., A.M., R.K.R.)
formed was filtered, washed with 95% ethanol, and dried in
thank NIDA Grant DA-05488 for financial support.
vacuo to give 2 (445 mg). The filtrate was concentrated and
dissolved in a water–ethanol mixture to give a second crop of
crystals of 2 (400 mg, 38.0% overall). Mp 238–2391C; 2H NMR
(H2O, deuterium depleted): d 3.99 (s, 2D), 3.17 (s, 2D); 31P NMR
References
(D2O): d 1.47; CIMS (m/z) calcd. for C2H3D4NO4P (M-H)ꢀ:
144.0364; Found: 144.0367; Anal. calcd. for C2H4D4NO4P: C,
16.56; H1D, 5.56; H, 9.65; Found: C, 16.60; H1D, 5.51; H, 9.62.
[1] W. A. Devane, L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G.
Griffin, D. Gibson, A. Mandelbaum, A. Etinger, R. Mechoulam,
Science 1992, 258, 1946–1949.
[2] V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.-C.
Schwartz, D. Piomelli, Nature 1994, 372, 686–691.
[3] D. Leung, A. Saghatelian, G. M. Simon, B. F. Cravatt, Biochemistry
2-(5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenamidoethyl-d4 dihydrogen
phosphate (4)
2006, 45, 4720–4726.
[4] J. Liu, L. Wang, J. Harvey-White, D. Osei-Hyiaman, R. K. Razdan, Z.
To a homogeneous stirred solution of 2-aminoethyl dihydrogen
phosphate-1,1,2,2-d4 (2, 85 mg, 0.58 mmol), sodium bicarbonate
(126 mg, 1.5 mmol) in water (2 mL), a solution of (5Z,8Z,11Z,14Z)-
Zhou, A. Chen, B. Huang, H. Y. Kim, G. Kunos, Proc. Natl. Acad. Sci.
U. S. A. 2006, 103, 13345–13350.
[5] J. Liu, L. Wang, J. Harvey-White, B. X. Huang, H.-Y. Kim, S. Luquet, R.
D. Palmiter, G. Krystal, R. Rai, A. Mahadevan, R. K. Razdan, G. Kunos,
Neuropharmacology 2008, 54, 1–7.
[6] J. H. Weissburger, W. C. Schneider, J. Org. Chem. 1961, 26,
1658–1660.
[7] T. Sheskin, L. Hanus, J. Slager, Z. Vogel, R. Mechoulam, J. Med.
Chem. 1997, 40, 659–667.
2,5-dioxopyrrolidin-1-yl
icosa-5,8,11,14-tetraenoate7
(3,
178.5 mg, 0.45 mmol) in THF (3.5 mL) was added dropwise
under nitrogen and the stirring was continued overnight at
room temperature. The reaction mixture was acidified to pH 2
with 0.1N HCl and extracted with CH2Cl2 (3 ꢁ 30 mL) and little
CHCl3 (3 mL). The organic layer was washed with water
Published in 2008 by John Wiley & Sons, Ltd
J. Label Compd. Radiopharm 2008, 51 389–390